For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research ...

A pediatric asthma subgroup at high risk for acute respiratory infections can be identified using 2 natural language processing algorithms.

Children with mild asthma at low risk for severe exacerbations may not need daily or as-needed ICS, as GINA guidelines recommend.

Discover a study showing budesonide–formoterol cuts childhood asthma attacks by 45%, offering a safer alternative to ...

Among pediatric patients with intermittent asthma, around one-third did not have significant acute care needs over a 2-year ...

In the first randomized controlled trial to investigate the use of a 2-in-1 inhaler as the sole reliever therapy for children ...

A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the ...

The results show that using a single 2-in-1 anti-inflammatory reliever inhaler – which combines the inhaled corticosteroid (ICS) budesonide and the fast-acting bronchodilator formoterol – reduced ...

Findings could redefine the treatment for millions of children worldwide with asthma, after this comparison of two types of asthma inhalers.